{"id":"NCT00737477","sponsor":"Hoffmann-La Roche","briefTitle":"A Study of Monthly Subcutaneous (SC) Mircera for Maintenance Treatment of Participants With Chronic Kidney Disease on Peritoneal Dialysis","officialTitle":"A Single Arm, Open-Label, Multicentre Study to Assess the Maintenance of Haemoglobin Levels With Once Monthly Subcutaneous Administration of C.E.R.A (Continuous Erythropoietin Receptor Activator) in Patients With Chronic Kidney Disease on Peritoneal Dialysis","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2008-09-30","primaryCompletion":"2011-07-31","completion":"2011-07-31","firstPosted":"2008-08-19","resultsPosted":"2016-07-28","lastUpdate":"2017-06-23"},"enrollment":96,"design":{"allocation":"NA","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Anemia"],"interventions":[{"type":"DRUG","name":"Methoxy polyethylene glycol-epoetin beta","otherNames":["Mircera","CERA"]}],"arms":[{"label":"Mircera in Renal Anemia","type":"EXPERIMENTAL"}],"summary":"This single-arm study will assess the efficacy and safety of monthly administration of SC Mircera for the maintenance of hemoglobin levels in participants with chronic kidney disease on peritoneal dialysis. Participants currently receiving maintenance treatment with SC erythropoietin stimulating agents (ESAs) will receive monthly SC injections of Mircera, with the starting dose derived from the last weekly ESA they had been receiving.","primaryOutcome":{"measure":"Percentage of Participants Who Maintained Average Hb Value Within Target Range During the EEP","timeFrame":"Weeks 16 to 24","effectByArm":[{"arm":"Mircera in CKD-Related Anemia","deltaMin":50,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":3,"exclusionCount":3},"locations":{"siteCount":52,"countries":["France"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":48,"n":96},"commonTop":["Bronchitis","Hypertension","Constipation","Diarrhoea","Oedema peripheral"]}}